Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Harlan Robins
Fred Hutchinson Cancer Research Center, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Adaptive Biotechnologies Corporation
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The research project includes the purchase of services from Adaptive Biotechnologies Corporation and Dr. Robins will be participating in the research in his role as the principal investigator at the awardee institution.
High-throughput sequencing of the T cell receptor in colorectal tumor infilt
PROJECT NARRATIVE An accurate prognosis assists both colorectal cancer patients and clinicians to develop a personalized treatment plan. The quantity and clonality of Tumor Infiltrating Lymphocytes (TILs) are independent and informative prognostic factors for colorectal cancer. However, the current methods to quantify TILs are not conducive to the clinical setting. We propose to develop a new colorectal cancer prognostic metric, and to develop a method to detect tumor progression, both based on quantitative and reproducible measures of TILs in tumor samples and in blood.
Filed on June 23, 2014.
Tell us what you know about Harlan Robins's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Harlan Robins filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Harlan Robins | Fred Hutchinson Cancer Research Center | Conflict of Interest | Adaptive Biotechnologies Corporation | $100,000 - $149,999 |
| Harlan Robins | Fred Hutchinson Cancer Research Center | Conflict of Interest | Adaptive Biotechnologies Corporation | $100,000 - $149,999 |
| Harlan Robins | Fred Hutchinson Cancer Research Center | Conflict of Interest | Adaptive Biotechnologies Corporation | Value cannot be readily determined |
| Harlan Robins | Fred Hutchinson Cancer Research Center | Conflict of Interest | Adaptive Biotechnologies Corporation | Value cannot be readily determined |
| Harlan Robins | Fred Hutchinson Cancer Research Center | Conflict of Interest | Adaptive Biotechnologies Corporation | Value cannot be readily determined |
| Harlan Robins | Fred Hutchinson Cancer Research Center | Conflict of Interest | Adaptive Biotechnologies Corporation | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.